Skip to content

Effect of Extracorporeal Shockwave Therapy on Healing After Meniscus Repair

Evaluation of the Healing-Promotion Effect of Extracorporeal Shockwave Therapy in Meniscus Repair

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs032250107
Enrollment
50
Registered
2025-05-19
Start date
2025-05-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meniscus injury Meniscus, Meniscus injury, Meniscus tear

Interventions

Extracorporeal shockwave therapy
D018218
Extracorporeal shockwave therapy, ESWT

Sponsors

Hashimoto Shogo
Lead Sponsor
Chikuda Hirotaka
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients aged 18 years or older. 2) Patients diagnosed with a meniscal tear by MRI and who have undergone arthroscopic meniscus repair. 3) Patients with a performance status (PS) of 0 to 1. 4) Patients who have provided written informed consent to participate in this study.

Exclusion criteria

Exclusion criteria: 1) Patients who have previously undergone extracorporeal shockwave therapy (ESWT) on the operated knee. 2) Patients with osteoarthritis classified as Grade 3 or higher according to the Kellgren-Lawrence classification in the operated knee. 3) Patients with concomitant cruciate ligament tears or intra-articular fractures in the operated knee. 4) Patients with a history of meniscectomy, meniscus repair, cruciate ligament reconstruction, or open reduction and internal fixation (ORIF) for periarticular fractures in the operated knee. 5) Patients determined by a physician to have cognitive impairment. 6) Patients with contraindications to MRI. 7) Patients with evident physeal plate persistence in the operated knee. 8) Patients with an infection in the operated knee. 9) Patients with untreated bleeding disorders such as hemophilia or those taking anticoagulant medication. 10) Patients with polyneuropathy. 11) Patients with polyarthritis. 12) Patients with malignant tumors. 13) Pregnant patients. 14) Patients deemed unsuitable for the study by the physician.

Design outcomes

Primary

MeasureTime frame
Healing rate of meniscal suture site in MRI evaluation at 12 months postoperatively.

Secondary

MeasureTime frame
NRS (Numerical Rating Scale for pain) Clinical Scores (Evaluation of KOOS, IKDC score, Lysholm score, and Tegner Activity score) Physical Examination Findings (Evaluation of joint effusion, range of motion, McMurray test, and Watson-Johnson test) MRI T2 Mapping Incidence of Diseases or Complications Frequency of Oral Painkiller Use per Week

Contacts

Public ContactShogo Hashimoto

Gunma university hospital

hshou25@gunam-u.ac.jp+81-27-220-8269

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026